Raymond Cohen Acquires 17,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Director Raymond Cohen purchased 17,000 shares of Kestra Medical Technologies stock in a transaction that occurred on Friday, March 7th. The shares were bought at an average price of $17.00 per share, for a total transaction of $289,000.00. Following the completion of the transaction, the director owned 29,994 shares in the company, valued at $509,898. The trade was a 130.83% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Kestra Medical Technologies Stock Performance

KMTS opened at $17.87 on Wednesday. The stock’s 50 day moving average is $16.22. The company has a debt-to-equity ratio of 0.20, a quick ratio of 6.72 and a current ratio of 6.72. Kestra Medical Technologies, Ltd. has a 1 year low of $13.25 and a 1 year high of $26.15.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company reduced their price target on Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating on the stock in a research report on Thursday, July 17th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $27.33.

Institutional Investors Weigh In On Kestra Medical Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $33,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in Kestra Medical Technologies in the 2nd quarter worth approximately $54,000. New York State Common Retirement Fund purchased a new stake in Kestra Medical Technologies in the 2nd quarter worth approximately $93,000. Virtu Financial LLC purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $210,000. Finally, Walleye Capital LLC purchased a new stake in Kestra Medical Technologies in the 2nd quarter worth approximately $166,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.